5 employees
Sensulin is a diabetes drug discovery company developing a once-a-day glucose-responsive insulin.
2011
Sensulin raised undisclosed on October 25, 2021
Investors: Cortado Ventures
Sensulin raised undisclosed on May 23, 2018
Investors: AngelMD